z-logo
open-access-imgOpen Access
An integrated cell‐free metabolic platform for protein production and synthetic biology
Author(s) -
Jewett Michael C,
Calhoun Kara A,
Voloshin Alexei,
Wuu Jessica J,
Swartz James R
Publication year - 2008
Publication title -
molecular systems biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 8.523
H-Index - 148
ISSN - 1744-4292
DOI - 10.1038/msb.2008.57
Subject(s) - synthetic biology , cell free protein synthesis , biology , systems biology , protein biosynthesis , biochemistry , cell free system , computational biology , cell , catabolism , metabolic engineering , microbiology and biotechnology , oxidative phosphorylation , metabolism , in vitro , enzyme
Cell‐free systems offer a unique platform for expanding the capabilities of natural biological systems for useful purposes, i.e. synthetic biology. They reduce complexity, remove structural barriers, and do not require the maintenance of cell viability. Cell‐free systems, however, have been limited by their inability to co‐activate multiple biochemical networks in a single integrated platform. Here, we report the assessment of biochemical reactions in an Escherichia coli cell‐free platform designed to activate natural metabolism, the Cytomim system. We reveal that central catabolism, oxidative phosphorylation, and protein synthesis can be co‐activated in a single reaction system. Never before have these complex systems been shown to be simultaneously activated without living cells. The Cytomim system therefore promises to provide the metabolic foundation for diverse ab initio cell‐free synthetic biology projects. In addition, we describe an improved Cytomim system with enhanced protein synthesis yields (up to 1200 mg/l in 2 h) and lower costs to facilitate production of protein therapeutics and biochemicals that are difficult to make in vivo because of their toxicity, complexity, or unusual cofactor requirements.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here